BOSTON--(BUSINESS WIRE)--Nov. 28, 2018--
Cell Ltd. (Nasdaq: GMDA), a leading cellular and immune therapeutics
company, today announced that Julian Adams, Ph.D., the company’s chief
executive officer, will participate in a fireside chat at the BMO
Capital Markets 2018 Prescriptions for Success Healthcare Conference onWednesday, December 12th at 1:20 p.m. ET in New York, NY.
A live webcast of the presentation will be available on the Investors
section of the Gamida Cell website, at www.gamida-cell.com
and will be available for at least 30 days following the event.
About Gamida Cell
Gamida Cell is a clinical stage
biopharmaceutical company leveraging its proprietary technology to
develop cell therapies that are designed to cure cancer and rare,
serious hematologic diseases. The company is leveraging its
nicotinamide-, or NAM-, based cell expansion technology to develop a
pipeline of products designed to address the limitations of cell
View source version on businesswire.com: https://www.businesswire.com/news/home/20181128005056/en/
Source: Gamida Cell Ltd.
Investor and Media Inquiries:
Jaren Irene Madden